MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and ...
Amgen’s most advanced obesity asset MariTide is entering Maritime—that is, a phase 3 program that includes two freshly ...
Amgen (NASDAQ:AMGN) stock in focus as company starts Phase 3 trials for obesity drug MariTide, aiming to challenge Eli Lilly ...
We know that weight loss drugs have been big winners for the companies that produce them. And now, biotech stock Amgen (AMGN) ...
We recently compiled a list of the 11 Best Undervalued Stocks to Invest in Now. In this article, we are going to take a look ...
Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...
Amgen (AMGN) is getting closer to challenging the weight-loss drug duopoly of Novo Nordisk (NVO), the maker of Ozempic and Wegovy, and Eli Lilly (LLY), which produces Zepbound.
CrowdStrike shares dropped 10% after issuing weak earnings guidance and signaled ongoing pressure from its global IT outage ...
22hon MSN
The Federal Housing Administration, a major provider of low-down-payment loan options for first-time homebuyers, is facing a ...
23hon MSN
Spearheaded by the Defense Innovation Unit, the Thunderforge program will work with Anduril, Microsoft and others to develop ...
Healthcare Analysts discuss Amgen’s ( AMGN) Late-Stage Pipeline In The Rare Autoimmune Disease Arena on an Analyst/Industry conference call to be held on March 7. Published first on TheFly – the ...
Harvard-trained psychologist Dr. Ellen Hendriksen reveals a simple conversational trick that can strengthen relationships and make you more relatable to others.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results